FdaApplication

ANDA 203534

Back to search

Identifiers

Properties

PropertyValue
applicant_nameJUBILANT GENERICS LTD
application_typeANDA
approval_date2015-02-23

Products (3)

ProductActive ingredientStrengthDosage form
IRBESARTANIRBESARTAN300MGTABLET;ORAL
IRBESARTANIRBESARTAN150MGTABLET;ORAL
IRBESARTANIRBESARTAN75MGTABLET;ORAL

3 products